A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

Name: A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet
Published: 2016
License: Public Domain

AstraZeneca · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

safety

high risk coronary artery disease, pharmacokinetics (pk), bioavailability (ba), safety, tolerability, healthy volunteers, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents